These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 35884049)
21. Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being. Flevari P; Livanis EG; Theodorakis GN; Zarvalis E; Mesiskli T; Kremastinos DT J Am Coll Cardiol; 2002 Aug; 40(3):499-504. PubMed ID: 12142117 [TBL] [Abstract][Full Text] [Related]
22. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study. Theodorakis GN; Leftheriotis D; Livanis EG; Flevari P; Karabela G; Aggelopoulou N; Kremastinos DT Europace; 2006 Mar; 8(3):193-8. PubMed ID: 16627439 [TBL] [Abstract][Full Text] [Related]
23. Video education to improve clinical skills in the prevention of and response to vasovagal syncopal episodes. Coakley A; Bailey A; Tao J; Liou YL; Champlain A; Ander M; Lake E Int J Womens Dermatol; 2020 Jun; 6(3):186-190. PubMed ID: 32637542 [TBL] [Abstract][Full Text] [Related]
24. Duration of treatment with oral rehydration salts for vasovagal syncope in children and adolescents. Wen C; Wang S; Zou R; Wang Y; Tan C; Xu Y; Wang C Turk J Pediatr; 2020; 62(5):820-825. PubMed ID: 33108085 [TBL] [Abstract][Full Text] [Related]
25. Predicting therapeutic efficacy of oral rehydration salts in children with vasovagal syncope. Du X; Tao C; Li X; Du J; Liao Y; Jin H Front Pediatr; 2023; 11():1164304. PubMed ID: 37124188 [TBL] [Abstract][Full Text] [Related]
26. Midodrine for the Prevention of Vasovagal Syncope : A Randomized Clinical Trial. Sheldon R; Faris P; Tang A; Ayala-Paredes F; Guzman J; Marquez M; Morillo CA; Krahn AD; Kus T; Ritchie D; Safdar S; Maxey C; Raj SR; Ann Intern Med; 2021 Oct; 174(10):1349-1356. PubMed ID: 34339231 [TBL] [Abstract][Full Text] [Related]
27. Predicting recurrence of vasovagal syncope: a simple risk score for the clinical routine. Aydin MA; Maas R; Mortensen K; Steinig T; Klemm H; Risius T; Meinertz T; Willems S; Morillo CA; Ventura R J Cardiovasc Electrophysiol; 2009 Apr; 20(4):416-21. PubMed ID: 19017338 [TBL] [Abstract][Full Text] [Related]
28. The effect of orthostatic training in the prevention of vasovagal syncope and its influencing factors. Zeng H; Ge K; Zhang W; Wang G; Guo L Int Heart J; 2008 Nov; 49(6):707-12. PubMed ID: 19075486 [TBL] [Abstract][Full Text] [Related]
29. Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. The International Rate-Drop Investigators Group. Benditt DG; Sutton R; Gammage MD; Markowitz T; Gorski J; Nygaard GA; Fetter J Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 2):832-9. PubMed ID: 9080522 [TBL] [Abstract][Full Text] [Related]
30. Midodrine hydrochloride in the treatment of vasovagal syncope. Mitro P; Trejbal D; Rybár AR Pacing Clin Electrophysiol; 1999 Nov; 22(11):1620-4. PubMed ID: 10598965 [TBL] [Abstract][Full Text] [Related]
31. The DDDR closed loop stimulation for the prevention of vasovagal syncope: results from the INVASY prospective feasibility registry. Occhetta E; Bortnik M; Vassanelli C; Europace; 2003 Apr; 5(2):153-62. PubMed ID: 12633640 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy. Sra J; Maglio C; Biehl M; Dhala A; Blanck Z; Deshpande S; Jazayeri MR; Akhtar M J Cardiovasc Electrophysiol; 1997 Jan; 8(1):42-6. PubMed ID: 9116967 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of catheter ablation in ganglionated plexus for malignant vasovagal syncope children. Li H; Shao W; Yu X; Gao L; Yuan Y Cardiol Young; 2024 Jul; 34(7):1571-1576. PubMed ID: 38572563 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial). Romme JJ; van Dijk N; Go-Schön IK; Reitsma JB; Wieling W Europace; 2011 Nov; 13(11):1639-47. PubMed ID: 21752826 [TBL] [Abstract][Full Text] [Related]
35. The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: a prospective and randomized study. Duygu H; Zoghi M; Turk U; Akyuz S; Ozerkan F; Akilli A; Erturk U; Onder R; Akin M Pacing Clin Electrophysiol; 2008 May; 31(5):592-6. PubMed ID: 18439174 [TBL] [Abstract][Full Text] [Related]
36. [Association of clinical features with different hemodynamic patterns in head-up tilt test in children with unexplained syncope]. Zhang QY; Du JB; Li WZ; Chen JJ Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(28):1962-5. PubMed ID: 16313771 [TBL] [Abstract][Full Text] [Related]
37. Dual-Chamber Pacing With Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope: The SPAIN Study. Baron-Esquivias G; Morillo CA; Moya-Mitjans A; Martinez-Alday J; Ruiz-Granell R; Lacunza-Ruiz J; Garcia-Civera R; Gutierrez-Carretero E; Romero-Garrido R J Am Coll Cardiol; 2017 Oct; 70(14):1720-1728. PubMed ID: 28958328 [TBL] [Abstract][Full Text] [Related]
38. [A multicenter study on treatment of autonomous nerve-mediated syncope in children with beta-receptor blocker]. Chen L; DU JB; Zhang QY; Wang C; DU ZD; Wang HW; Tian H; Chen JJ; Wang YL; Hu XF; Li WZ; Han L Zhonghua Er Ke Za Zhi; 2007 Dec; 45(12):885-8. PubMed ID: 18339272 [TBL] [Abstract][Full Text] [Related]
39. Strategy for the management of vasovagal syncope. Bloomfield DM Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777 [TBL] [Abstract][Full Text] [Related]
40. Does cardiac pacing reduce syncopal recurrences in cardioinhibitory vasovagal syncope patients selected with head-up tilt test? Analysis of a 5-year follow-up database. Russo V; Rago A; De Rosa M; Papa AA; Simova I; Petrov I; Bonev N; Gargaro A; Golino P; Nigro G Int J Cardiol; 2018 Nov; 270():149-153. PubMed ID: 29980368 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]